These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33692737)

  • 1. Inside the Thrombus: Association of Hemostatic Parameters With Outcomes in Large Vessel Stroke Patients.
    Marta-Enguita J; Navarro-Oviedo M; Muñoz R; Olier-Arenas J; Zalba G; Lecumberri R; Mendioroz M; Paramo JA; Roncal C; Orbe J
    Front Neurol; 2021; 12():599498. PubMed ID: 33692737
    [No Abstract]   [Full Text] [Related]  

  • 2. How Clot Composition Influences Fibrinolysis in the Acute Phase of Stroke: A Proteomic Study of Cerebral Thrombi.
    Doche E; Sulowski C; Guigonis JM; Graslin F; Casolla B; Hak JF; Carle X; Brunel H; Lindenthal S; Martin JC; Pourcher T; Suissa L;
    Stroke; 2024 Jul; 55(7):1818-1829. PubMed ID: 38771990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High thrombin-activatable fibrinolysis inhibitor expression in thrombi from stroke patients in elevated estrogen states.
    Agarwal T; Mereuta OM; Ghozy S; Larco JLA; Bilgin C; Kadirvel R; Brinjikji W; Kallmes DF
    BMC Neurol; 2024 Mar; 24(1):90. PubMed ID: 38454378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of von Willebrand Factor, ADAMTS13, and Cerebral Artery Thrombus Composition in Patient Outcome Following Mechanical Thrombectomy for Acute Ischemic Stroke.
    Prochazka V; Jonszta T; Czerny D; Krajca J; Roubec M; Macak J; Kovar P; Kovarova P; Pulcer M; Zoubkova R; Lochman I; Svachova V; Pavliska L; Vrtkova A; Kasprak D; Gumulec J; Weisel JW
    Med Sci Monit; 2018 Jun; 24():3929-3945. PubMed ID: 29887594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similar hemostatic responses to hypovolemia induced by hemorrhage and lower body negative pressure reveal a hyperfibrinolytic subset of non-human primates.
    Zaar M; Herzig MC; Fedyk CG; Montgomery RK; Prat N; Parida BK; Hinojosa-Laborde C; Muniz GW; Shade RE; Bauer C; Delacruz W; Bynum JA; Convertino VA; Cap AP; Pidcoke HF
    PLoS One; 2020; 15(6):e0234844. PubMed ID: 32579572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent Thrombolytic Effect of
    Martinez de Lizarrondo S; Gakuba C; Herbig BA; Repessé Y; Ali C; Denis CV; Lenting PJ; Touzé E; Diamond SL; Vivien D; Gauberti M
    Circulation; 2017 Aug; 136(7):646-660. PubMed ID: 28487393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of ischemic stroke associated with functional thrombin-activatable fibrinolysis inhibitor plasma levels.
    Santamaría A; Oliver A; Borrell M; Mateo J; Belvis R; Martí-Fábregas J; Ortín R; Tirado I; Souto JC; Fontcuberta J
    Stroke; 2003 Oct; 34(10):2387-91. PubMed ID: 12947154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with essential arterial hypertension.
    Małyszko J; Tymcio J
    Pol Arch Med Wewn; 2008; 118(1-2):36-41. PubMed ID: 18405171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling Large Vessel Occlusion Stroke for the Evaluation of Endovascular Therapy According to Thrombus Composition.
    Freiherr von Seckendorff A; Delvoye F; Levant P; Solo Nomenjanahary M; Ollivier V; Bourrienne MC; Di Meglio L; Piotin M; Escalard S; Maier B; Hebert S; Smajda S; Redjem H; Mazighi M; Blanc R; Ho-Tin-Noé B; Désilles JP
    Front Neurol; 2021; 12():815814. PubMed ID: 35153990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythrocyte-Rich Thrombus Is Associated with Reduced Number of Maneuvers and Procedure Time in Patients with Acute Ischemic Stroke Undergoing Mechanical Thrombectomy.
    Maekawa K; Shibata M; Nakajima H; Mizutani A; Kitano Y; Seguchi M; Yamasaki M; Kobayashi K; Sano T; Mori G; Yabana T; Naito Y; Shimizu S; Miya F
    Cerebrovasc Dis Extra; 2018; 8(1):39-49. PubMed ID: 29402828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Composition and Organization of Acute Ischemic Stroke Thrombus: A Wealth of Information for Future Thrombolytic Strategies.
    Desilles JP; Di Meglio L; Delvoye F; Maïer B; Piotin M; Ho-Tin-Noé B; Mazighi M
    Front Neurol; 2022; 13():870331. PubMed ID: 35873787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of functional thrombin-activatable fibrinolysis inhibitor (TAFI) with conventional cardiovascular risk factors and its correlation with other hemostatic factors in a Spanish population.
    Santamaría A; Borrell M; Oliver A; Ortín R; Forner R; Coll I; Mateo J; Souto JC; Fontcuberta J
    Am J Hematol; 2004 Aug; 76(4):348-52. PubMed ID: 15282667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythrocyte Fraction Within Retrieved Thrombi Contributes to Thrombolytic Response in Acute Ischemic Stroke.
    Choi MH; Park GH; Lee JS; Lee SE; Lee SJ; Kim JH; Hong JM
    Stroke; 2018 Mar; 49(3):652-659. PubMed ID: 29374103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of TAFI increases brain damage and microparticle generation after thrombolytic therapy in ischemic stroke.
    Orbe J; Alexandru N; Roncal C; Belzunce M; Bibiot P; Rodriguez JA; Meijers JC; Georgescu A; Paramo JA
    Thromb Res; 2015 Aug; 136(2):445-50. PubMed ID: 26118976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombin-activatable fibrinolysis inhibitor (TAFI) antigen and activity assay in patients with primary hypothyroidism.
    Ermantas N; Guldiken S; Demir M; Tugrul A
    Clin Appl Thromb Hemost; 2010 Oct; 16(5):568-73. PubMed ID: 19959491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rivaroxaban attenuates thrombosis by targeting the NF-κB signaling pathway in a rat model of deep venous thrombus.
    Ma J; Li X; Wang Y; Yang Z; Luo J
    Int J Mol Med; 2017 Dec; 40(6):1869-1880. PubMed ID: 29039441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrin to von Willebrand factor ratio in arterial thrombi is associated with plasma levels of inflammatory biomarkers and local abundance of extracellular DNA.
    Tóth E; Beinrohr L; Gubucz I; Szabó L; Tenekedjiev K; Nikolova N; Nagy AI; Hidi L; Sótonyi P; Szikora I; Merkely B; Kolev K
    Thromb Res; 2022 Jan; 209():8-15. PubMed ID: 34844046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation and regulation of platelet and fibrin hemostatic plug.
    Hawiger J
    Hum Pathol; 1987 Feb; 18(2):111-22. PubMed ID: 3804319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a TAFI-inhibitor combined with a suboptimal dose of rtPA in a murine thromboembolic model of stroke.
    Durand A; Chauveau F; Cho TH; Kallus C; Wagner M; Boutitie F; Maucort-Boulch D; Berthezène Y; Wiart M; Nighoghossian N
    Cerebrovasc Dis; 2014; 38(4):268-75. PubMed ID: 25401979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombin activatable fibrinolysis inhibitor and its relationship to fibrinolysis and inflammation during the acute and convalescent phase of ischemic stroke.
    Rooth E; Wallen H; Antovic A; von Arbin M; Kaponides G; Wahlgren N; Blombäck M; Antovic J
    Blood Coagul Fibrinolysis; 2007 Jun; 18(4):365-70. PubMed ID: 17473579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.